{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:09:19Z","timestamp":1779314959231,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.thromres.2021.12.002","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T11:28:40Z","timestamp":1638790120000},"page":"75-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia"],"prefix":"10.1016","volume":"209","author":[{"given":"Yumei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zonghong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.12.002_bb0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/vaccines9040393","article-title":"Analysis of thrombotic adverse reactions of COVID-19 AstraZeneca vaccine reported to EudraVigilance database","volume":"9","author":"Tobaiqy","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.thromres.2021.12.002_bb0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.12.002_bb0015","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2021","key":"10.1016\/j.thromres.2021.12.002_bb0020","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination","volume":"325","author":"See","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2021.12.002_bb0025","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0030","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0035","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7017e4","article-title":"Updated recommendations from the Advisory Committee on Immunization Practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients - United States, April 2021","volume":"70","author":"MacNeil","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.thromres.2021.12.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012896","article-title":"Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis","author":"Palaiodimou","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.thromres.2021.12.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2021.3619","article-title":"Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","author":"S\u00e1nchez van Kammen","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.thromres.2021.12.002_bb0055","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","article-title":"Epidemiology and risk factors for venous thrombosis","volume":"44","author":"Cushman","year":"2007","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.thromres.2021.12.002_bb0065","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2021.06.001","article-title":"Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19","volume":"78","author":"Bikdeli","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2021.12.002_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117532","article-title":"Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions","volume":"427","author":"Thakur","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.thromres.2021.12.002_bb0075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrneurol.2017.104","article-title":"Cerebral venous thrombosis","volume":"13","author":"Silvis","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.thromres.2021.12.002_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejim.2021.05.031","article-title":"Thrombosis with thrombocytopenia syndrome associated with viral vector COVID-19 vaccines","volume":"89","author":"Cattaneo","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0085","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.chest.2017.03.050","article-title":"IVIg for treatment of severe refractory heparin-induced thrombocytopenia","volume":"152","author":"Padmanabhan","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2021.12.002_bb0090","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1161\/STROKEAHA.121.035613","article-title":"Cerebral vein thrombosis with vaccine-induced immune thrombotic thrombocytopenia","volume":"52","author":"Siegler","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2021.12.002_bb0095","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.12.002_bb0100","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1093\/eurheartj\/ehab506","article-title":"Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia","volume":"42","author":"Holm","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2021.12.002_bb0105","series-title":"Anti-PF4 VITT Antibodies Are Oligoclonal and Variably Inhibited by Heparin","author":"Singh","year":"2021"},{"key":"10.1016\/j.thromres.2021.12.002_bb0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2021.12.002_bb0115","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2021012938","article-title":"Anti\u2013platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.12.002_bb0120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2021.12.002_bb0125","doi-asserted-by":"crossref","first-page":"10791","DOI":"10.3390\/ijms221910791","article-title":"Coagulopathies after vaccination against SARS-CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways","volume":"22","author":"Kircheis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2021.12.002_bb0130","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT)-update on diagnosis and management considering different resources","author":"Greinacher","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.12.002_bb0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(21)01608-1","article-title":"Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study","volume":"398","author":"Perry","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2021.12.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1055\/a-1681-7286","article-title":"Vaccine induced thrombotic thrombocytopenia: insights from blood smear","author":"Zimmermann","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.12.002_bb0145","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMc2112760","article-title":"Decline in pathogenic antibodies over time in VITT","volume":"385","author":"Sch\u00f6nborn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0155","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.15341","article-title":"Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: communication from the ISTH SSC Subcommittee on Platelet Immunology","volume":"19","author":"Nazy","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.12.002_bb0160","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2112974","article-title":"Vaccine-induced thrombocytopenia with severe headache","author":"Salih","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0170","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/jth.15361","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VIPIT): consider IVIG batch in the treatment","volume":"19","author":"Karnam","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.12.002_bb0175","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-associated immune thrombocytopenia and thrombosis","author":"Pavord","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0180","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJMc2109465","article-title":"Therapeutic plasma exchange in vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Patriquin","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0185","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjmed.2008.03.012","article-title":"A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia","volume":"121","author":"Warkentin","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0190","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1055\/a-1481-3039","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors","volume":"121","author":"von Hundelshausen","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.12.002_bb0195","article-title":"VITT after ChAdOx1 nCoV-19 vaccination","author":"Weber","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.12.002_bb0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2016000877","article-title":"Polyphosphate\/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia","volume":"1","author":"Cines","year":"2016","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2021.12.002_bb0205","article-title":"Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2021.12.002_bb0210","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jth.15352","article-title":"An observational study to identify the prevalence of thrombocytopenia and anti-PF4\/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination","volume":"19","author":"S\u00f8rvoll","year":"2021","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821005557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821005557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:46:47Z","timestamp":1758736007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821005557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S0049384821005557"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.12.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}